Heron Therapeutics
HRTX
#8261
Rank
โ‚น21.59 B
Marketcap
โ‚น117.76
Share price
0.00%
Change (1 day)
-20.52%
Change (1 year)

Heron Therapeutics (HRTX) - Total assets

Total assets on the balance sheet as of September 2025 : โ‚น22.37 Billion

According to Heron Therapeutics's latest financial reports the company's total assets are โ‚น22.37 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Heron Therapeutics - Total assets on balance sheet (from 2001 to 2025)

Total assets by year

Year Total assets Change
2024-12-31โ‚น20.00 B7.98%
2023-12-31โ‚น18.52 B-10.8%
2022-12-31โ‚น20.76 B-8.74%
2021-12-31โ‚น22.75 B-12%
2020-12-31โ‚น25.85 B-29.29%
2019-12-31โ‚น36.56 B13.15%
2018-12-31โ‚น32.31 B116.01%
2017-12-31โ‚น14.96 B226.24%
2016-12-31โ‚น4.58 B-49.94%
2015-12-31โ‚น9.16 B88.49%
2014-12-31โ‚น4.85 B3.59%
2013-12-31โ‚น4.69 B53.08%
2012-12-31โ‚น3.06 B197.93%
2011-12-31โ‚น1.02 B688.58%
2010-12-31โ‚น0.13 B-68.59%
2009-12-31โ‚น0.41 B-26.77%
2008-12-31โ‚น0.56 B-60.89%
2007-12-31โ‚น1.45 B89.79%
2006-12-31โ‚น0.76 B89.31%
2005-12-31โ‚น0.40 B-45.23%
2004-12-31โ‚น0.73 B23.02%
2003-12-31โ‚น0.59 B-29.76%
2002-12-31โ‚น0.85 B-24.82%
2001-12-31โ‚น1.13 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Alkermes
ALKS
โ‚น209.41 B 835.73%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Pacira Biosciences
PCRX
โ‚น116.64 B 421.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
โ‚น27.08 B 21.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
โ‚น132.75 B 493.20%๐Ÿ‡บ๐Ÿ‡ธ USA
SurModics
SRDX
โ‚น15.26 B-31.78%๐Ÿ‡บ๐Ÿ‡ธ USA